Kenalog-40 Alternatives Compared
| Kenalog-40 Remove Kenalog-40 from your drug comparison | Meloxicam Remove Meloxicam from your drug comparison | Celebrex Remove Celebrex from your drug comparison |
|---|
| Kenalog-40 triamcinolone Remove Kenalog-40 from your drug comparison | Meloxicam Remove Meloxicam from your drug comparison | Celebrex celecoxib Remove Celebrex from your drug comparison | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Alopecia, Allergic Rhinitis, Allergic Reactions, Osteoarthritis, Adrenocortical Insufficiency, Bursitis, Keloids, Synovitis, Sarcoidosis, Rheumatoid Arthritis, Psoriatic Arthritis,... View more |
Meloxicam is effective for the short-term relief of pain and inflammation associated with arthritis; however, like other NSAIDs, it has the potential to adversely affect the stomach or heart and... View more |
Celebrex is effective for the short-term relief of acute pain, and pain and inflammation associated with arthritis, menstruation, and Ankylosing Spondylitis. Risk of symptomatic ulcers is lower with... View more |
||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
|
See the full Kenalog-40 side effects document. |
See the full meloxicam side effects document. |
Common side effects include: diarrhea, hypertension, abnormal hepatic function tests. See the full Celebrex side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all Kenalog-40 prices and generic prices |
View all meloxicam prices |
View all Celebrex prices and generic prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
|
Yes (this medicine) |
||||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
| Other triamcinolone brands include: Aristospan, Aristospan Intra-Articular, Aristospan Intralesional, Clinacort, Kenalog-10, Zilretta | Anjeso, Mobic, Vivlodex | Other celecoxib brands include: Elyxyb | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
|
36 hours |
20 hours |
11 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
|
A total of 495 drugs are known to interact with Kenalog-40:
|
A total of 355 drugs are known to interact with meloxicam:
|
A total of 359 drugs are known to interact with Celebrex:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
|
N/A |
April 13, 2000 |
December 31, 1998 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.